仿制药制造商Viatris已在特拉华州联邦法院起诉丹麦制药巨头诺和诺德，寻求裁定其拟推出的诺和诺德重磅GLP-1药物Wegovy的仿制药不会侵犯诺和诺德的专利权。
Generic drugmaker Viatris has sued Danish pharmaceutical giant Novo Nordisk in Delaware federal court, seeking a ruling that its proposed generic of Novo's blockbuster GLP-1 drug Wegovy would not violate Novo's patent rights.